This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock CYAN vs. BGXX, HAPP, IMCC, AKAN, BON, SMFL, CRON, CDXC, USNA, and MNMDShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Bright Green (BGXX), Happiness Development Group (HAPP), IM Cannabis (IMCC), Akanda (AKAN), Bon Natural Life (BON), Smart for Life (SMFL), Cronos Group (CRON), ChromaDex (CDXC), USANA Health Sciences (USNA), and Mind Medicine (MindMed) (MNMD). These companies are all part of the "medicinals & botanicals" industry. Cyanotech vs. Bright Green Happiness Development Group IM Cannabis Akanda Bon Natural Life Smart for Life Cronos Group ChromaDex USANA Health Sciences Mind Medicine (MindMed) Bright Green (NASDAQ:BGXX) and Cyanotech (NASDAQ:CYAN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation, dividends and community ranking. Is BGXX or CYAN more profitable? Bright Green has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Cyanotech's return on equity of -44.71% beat Bright Green's return on equity.Company Net Margins Return on Equity Return on Assets Bright GreenN/A -88.37% -55.30% Cyanotech -19.50%-44.71%-19.12% Do insiders & institutionals have more ownership in BGXX or CYAN? 7.8% of Bright Green shares are held by institutional investors. Comparatively, 24.4% of Cyanotech shares are held by institutional investors. 62.5% of Bright Green shares are held by company insiders. Comparatively, 29.1% of Cyanotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, BGXX or CYAN? Bright Green has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500. Comparatively, Cyanotech has a beta of -0.11, suggesting that its stock price is 111% less volatile than the S&P 500. Which has stronger earnings & valuation, BGXX or CYAN? Cyanotech has higher revenue and earnings than Bright Green. Cyanotech is trading at a lower price-to-earnings ratio than Bright Green, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright GreenN/AN/A-$13.13M-$0.06N/ACyanotech$23.07M0.13-$5.27M-$0.66-0.63 Does the MarketBeat Community favor BGXX or CYAN? Cyanotech received 128 more outperform votes than Bright Green when rated by MarketBeat users. CompanyUnderperformOutperformBright GreenN/AN/ACyanotechOutperform Votes12863.68% Underperform Votes7336.32% Does the media refer more to BGXX or CYAN? In the previous week, Bright Green's average media sentiment score of 0.00 equaled Cyanotech'saverage media sentiment score. Company Overall Sentiment Bright Green Neutral Cyanotech Neutral SummaryCyanotech beats Bright Green on 8 of the 11 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.99M$1.18B$5.46B$8.49BDividend YieldN/AN/A5.26%4.19%P/E Ratio-0.6311.7427.1119.89Price / Sales0.1311.00410.33133.61Price / CashN/A10.4038.2534.64Price / Book0.311.516.884.60Net Income-$5.27M-$54.34M$3.23B$247.54M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotechN/A$0.42-0.1%N/A+11.3%$2.99M$23.07M-0.6395BGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownHAPPHappiness Development GroupN/A$1.00-6.5%N/A+5.8%$6.96M$95.59M2.08215Positive NewsIMCCIM Cannabis1.0912 of 5 stars$1.89-0.8%N/A-14.5%$4.23M$54.47M-0.56340Short Interest ↓AKANAkandaN/A$1.26flatN/A-71.3%$1.80M$836,664.000.00110News CoverageShort Interest ↓Gap UpBONBon Natural LifeN/A$1.91+6.1%N/A-96.9%$319,000.00$23.84M0.00100News CoveragePositive NewsSMFLSmart for LifeN/A$0.00-75.2%N/A-99.8%$18,000.00$11.11M0.00110Gap UpHigh Trading VolumeCRONCronos Group1.8369 of 5 stars$2.05+0.7%N/A-22.8%$788.16M$124.59M-15.73450Positive NewsShort Interest ↓CDXCChromaDex2.5484 of 5 starsN/A$9.03+∞N/A$611.50M$99.60M787.29120USNAUSANA Health Sciences4.1524 of 5 stars$30.15+2.5%$36.00+19.4%-39.1%$559.25M$876.24M10.611,900MNMDMind Medicine (MindMed)1.8973 of 5 stars$7.29-0.1%$25.11+244.5%-7.3%$549.81MN/A-3.2340News Coverage Related Companies and Tools Related Companies BGXX Competitors HAPP Competitors IMCC Competitors AKAN Competitors BON Competitors SMFL Competitors CRON Competitors CDXC Competitors USNA Competitors MNMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 6/5/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
